mepivacaine has been researched along with Cancer of Nose in 1 studies
Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, H | 1 |
| Häberle, M | 1 |
| Hornstein, OP | 1 |
1 other study available for mepivacaine and Cancer of Nose
| Article | Year |
|---|---|
[Transient vision loss caused by scandicaine with added arterenol in the excision of basalioma of the side of the nose].
Topics: Aged; Aged, 80 and over; Anesthetics, Local; Blindness; Carcinoma, Basal Cell; Female; Humans; Mepiv | 1987 |